JP2022500452A5 - - Google Patents

Info

Publication number
JP2022500452A5
JP2022500452A5 JP2021514400A JP2021514400A JP2022500452A5 JP 2022500452 A5 JP2022500452 A5 JP 2022500452A5 JP 2021514400 A JP2021514400 A JP 2021514400A JP 2021514400 A JP2021514400 A JP 2021514400A JP 2022500452 A5 JP2022500452 A5 JP 2022500452A5
Authority
JP
Japan
Prior art keywords
approximately
composition
composition according
inhibitor
day
Prior art date
Application number
JP2021514400A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020056191A5 (https=
JP2022500452A (ja
JP7777448B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/050890 external-priority patent/WO2020056191A1/en
Publication of JP2022500452A publication Critical patent/JP2022500452A/ja
Publication of JPWO2020056191A5 publication Critical patent/JPWO2020056191A5/ja
Publication of JP2022500452A5 publication Critical patent/JP2022500452A5/ja
Priority to JP2025088639A priority Critical patent/JP2025138639A/ja
Application granted granted Critical
Publication of JP7777448B2 publication Critical patent/JP7777448B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021514400A 2018-09-13 2019-09-12 プラスミノーゲンアクチベーターインヒビター1(plasminogen activator inhibitor 1)(PAI-1)阻害剤(inhibitor)の使用 Active JP7777448B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025088639A JP2025138639A (ja) 2018-09-13 2025-05-28 プラスミノーゲンアクチベーターインヒビター1(plasminogen activator inhibitor 1)(PAI-1)阻害剤(inhibitor)の使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862731076P 2018-09-13 2018-09-13
US62/731,076 2018-09-13
PCT/US2019/050890 WO2020056191A1 (en) 2018-09-13 2019-09-12 Uses of plasminogen activator inhibitor 1 (pai-1) inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025088639A Division JP2025138639A (ja) 2018-09-13 2025-05-28 プラスミノーゲンアクチベーターインヒビター1(plasminogen activator inhibitor 1)(PAI-1)阻害剤(inhibitor)の使用

Publications (4)

Publication Number Publication Date
JP2022500452A JP2022500452A (ja) 2022-01-04
JPWO2020056191A5 JPWO2020056191A5 (https=) 2022-09-21
JP2022500452A5 true JP2022500452A5 (https=) 2022-09-21
JP7777448B2 JP7777448B2 (ja) 2025-11-28

Family

ID=68073184

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021514400A Active JP7777448B2 (ja) 2018-09-13 2019-09-12 プラスミノーゲンアクチベーターインヒビター1(plasminogen activator inhibitor 1)(PAI-1)阻害剤(inhibitor)の使用
JP2025088639A Pending JP2025138639A (ja) 2018-09-13 2025-05-28 プラスミノーゲンアクチベーターインヒビター1(plasminogen activator inhibitor 1)(PAI-1)阻害剤(inhibitor)の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025088639A Pending JP2025138639A (ja) 2018-09-13 2025-05-28 プラスミノーゲンアクチベーターインヒビター1(plasminogen activator inhibitor 1)(PAI-1)阻害剤(inhibitor)の使用

Country Status (12)

Country Link
US (1) US20220079911A1 (https=)
EP (1) EP3849540A1 (https=)
JP (2) JP7777448B2 (https=)
KR (2) KR20250161056A (https=)
CN (2) CN113056269A (https=)
AU (1) AU2019339488B2 (https=)
BR (1) BR112021004550A2 (https=)
CA (1) CA3112549A1 (https=)
IL (1) IL281451A (https=)
MX (2) MX2021002994A (https=)
SG (1) SG11202102479TA (https=)
WO (1) WO2020056191A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017360346B2 (en) 2016-11-21 2023-11-23 Eirion Therapeutics, Inc. Transdermal delivery of large agents
AU2024344613A1 (en) * 2023-09-18 2026-04-23 Eirion Therapeutics, Inc. Topical compositions and uses of pai-1 inhibitors
CN117919248B (zh) * 2024-03-22 2024-06-04 四川兴泰普乐医疗科技有限公司 一种可注射生发组合物及其制备方法和应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US296006A (en) 1884-04-01 John hoefleb
US4270537A (en) 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
US4886499A (en) 1986-12-18 1989-12-12 Hoffmann-La Roche Inc. Portable injection appliance
GB8704027D0 (en) 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
FR2638359A1 (fr) 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
US5008110A (en) 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5190521A (en) 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
SE9102652D0 (sv) 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
US5328483A (en) 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
US6010715A (en) 1992-04-01 2000-01-04 Bertek, Inc. Transdermal patch incorporating a polymer film incorporated with an active agent
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
IT1261849B (it) 1993-09-02 1996-06-03 Avantgarde Spa Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
US6461596B1 (en) * 1997-02-18 2002-10-08 Andrea Taylor Composition and method for promoting hair growth
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
US5965154A (en) 1998-03-17 1999-10-12 Plc Holding, L.L.C. Adhesive matrix type transdermal patch and method of manufacturing same
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US6908453B2 (en) 2002-01-15 2005-06-21 3M Innovative Properties Company Microneedle devices and methods of manufacture
US20060058369A1 (en) * 2002-02-19 2006-03-16 Vanderbilt University Therapeutic methods employing PAI-1 inhibitors and transgenic non-human animal for screening candidate PAI-1 inhibitors
WO2003071267A1 (en) * 2002-02-19 2003-08-28 Vanderbilt University Therapeutic methods employing pai-1 inhibitors and transgenic non-human animal for screening candidate pai-1 inhibitors
EP1509236A4 (en) * 2002-05-13 2008-07-30 Children S Hospital Los Angele TREATMENT AND PREVENTION OF ABNORMAL SCALING IN KELOIDS AND OTHER SKIN OR INTERNAL WOUNDS OR LESIONS
BRPI0619134B8 (pt) 2005-12-01 2021-05-25 Univ Massachusetts Lowell nanoemulsão, composição farmacêutica, composição, métodos cosméticos para o tratamento de rugas, linhas faciais e/ou linhas do pescoço, e de retardar o início das rugas, linhas faciais e/ou linhas do pescoço, e, método de fabricação de uma nanoemulsão
EP2015773A4 (en) 2006-04-27 2010-05-05 Anterios Inc EXAMINATION OF THE EFFECTS OF TOPICAL ADMINISTRATION OF CHEMICALLY DENOMINATING PHARMACEUTICALS
CA2691214A1 (en) * 2006-06-09 2007-12-21 Kemia, Inc. Therapy using cytokine inhibitors
WO2008070538A2 (en) 2006-12-01 2008-06-12 Anterios, Inc. Micellar nanoparticles comprising botulinum toxin
WO2009123241A1 (ja) * 2008-03-31 2009-10-08 株式会社レナサイエンス プラスミノーゲンアクチベーターインヒビター-1阻害剤
WO2009143865A1 (en) * 2008-05-30 2009-12-03 Xigen S.A. Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
MX379265B (es) 2008-06-26 2025-03-11 Anterios Inc Aplicacion dérmica de toxina botulínica en nanoemulsiones para usarse en el tratamiento de trastornos de la piel.
US20110112041A1 (en) * 2009-10-01 2011-05-12 Baylor Research Institute Treatment of Male-Pattern Baldness by Local Induction of the Metabolic Defect of Fabry Disease
KR20140005998A (ko) 2011-01-24 2014-01-15 안테리오스, 인코퍼레이티드 나노입자 조성물, 이의 제형, 및 그의 용도
EP2667854B1 (en) 2011-01-24 2019-01-16 Anterios, Inc. Nanoparticle compositions
WO2013096026A1 (en) 2011-12-21 2013-06-27 3M Innovative Properties Company Transdermal adhesive patch assembly with removable microneedle array and method of using same
CN103479627A (zh) * 2013-05-16 2014-01-01 武汉光谷百桥国际生物科技有限公司 一种血管紧张素ii的i型受体拮抗剂在促进毛发生长方面的应用
CN115998740A (zh) * 2014-10-29 2023-04-25 萨姆森临床私人有限公司 毛发过度脱落的检测和治疗
US20160144001A1 (en) * 2014-11-21 2016-05-26 Northwestern University Methods and compositions for modulating fgf23 levels

Similar Documents

Publication Publication Date Title
Hordinsky et al. Alopecia areata: an evidence-based treatment update
US20120328549A1 (en) Oil compositions
JP2022500452A5 (https=)
JP2014503587A (ja) 界面活性剤組成物
AU2017202440A1 (en) Nanoparticle compositions, formulations thereof, and uses therefor
EA200870393A1 (ru) Новые композиции для нарушений волос и способ получения композиций
EP3572072A1 (en) Nanoparticle compositions
SG193971A1 (en) Compositions of empty nanoparticles and their use for treating dermatological conditions
JP2014507420A (ja) パラベン組成物
Burnett et al. The nitric oxide signaling pathway in the penis
JP2021535925A5 (https=)
JP2012152127A (ja) 皮膚バリア機能回復剤
KR102884804B1 (ko) 플라즈미노겐 활성인자 억제제 1 (pai-1) 억제제의 용도
JPWO2020056191A5 (https=)
US8697146B2 (en) Poly-hapten with topical hormone alopecia hair regrowth system
JP2002516846A (ja) 小分子スルホンアミド発毛組成物および使用
TWI516272B (zh) 應用於生髮之方法及醫藥組成物
JPWO2020056160A5 (https=)
US8580236B2 (en) Hair sustaining formulation
JP2023539558A (ja) 毛成長調節に使用するためのイオンチャネルの活性を調節する活性剤
CN1946372A (zh) 使用热休克蛋白抑制剂来减少毛发生长
US20130079312A1 (en) Method of Treating Hair Loss Due to Systemic Chemotherapy
WO2017069113A1 (ja) 発毛促進組成物およびその使用
JP2007510725A5 (https=)
WO2023056029A1 (en) Beta3-adrenergic agonists for treatment of disorders of hair growth